264 related articles for article (PubMed ID: 16200082)
1. Regulation of MHC class II gene expression by the class II transactivator.
Reith W; LeibundGut-Landmann S; Waldburger JM
Nat Rev Immunol; 2005 Oct; 5(10):793-806. PubMed ID: 16200082
[TBL] [Abstract][Full Text] [Related]
2. Class II transactivator: mastering the art of major histocompatibility complex expression.
Harton JA; Ting JP
Mol Cell Biol; 2000 Sep; 20(17):6185-94. PubMed ID: 10938095
[No Abstract] [Full Text] [Related]
3. Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4⁺ T cells.
Hepworth MR; Fung TC; Masur SH; Kelsen JR; McConnell FM; Dubrot J; Withers DR; Hugues S; Farrar MA; Reith W; Eberl G; Baldassano RN; Laufer TM; Elson CO; Sonnenberg GF
Science; 2015 May; 348(6238):1031-5. PubMed ID: 25908663
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of MHC class II gene expression by CXCR4.
Sheridan C; Sadaria M; Bhat-Nakshatri P; Goulet R; Edenberg HJ; McCarthy BP; Chang CH; Srour EF; Nakshatri H
Exp Hematol; 2006 Aug; 34(8):1085-92. PubMed ID: 16863915
[TBL] [Abstract][Full Text] [Related]
5. CIITA and Its Dual Roles in MHC Gene Transcription.
Devaiah BN; Singer DS
Front Immunol; 2013 Dec; 4():476. PubMed ID: 24391648
[TBL] [Abstract][Full Text] [Related]
6. Regulation of MHC class II genes: lessons from a disease.
Mach B; Steimle V; Martinez-Soria E; Reith W
Annu Rev Immunol; 1996; 14():301-31. PubMed ID: 8717517
[TBL] [Abstract][Full Text] [Related]
7. Present Yourself! By MHC Class I and MHC Class II Molecules.
Rock KL; Reits E; Neefjes J
Trends Immunol; 2016 Nov; 37(11):724-737. PubMed ID: 27614798
[TBL] [Abstract][Full Text] [Related]
8. The MHC Class II Transactivator CIITA: Not (Quite) the Odd-One-Out Anymore among NLR Proteins.
León Machado JA; Steimle V
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499042
[TBL] [Abstract][Full Text] [Related]
9. The ins and outs of MHC class II-mediated antigen processing and presentation.
Roche PA; Furuta K
Nat Rev Immunol; 2015 Apr; 15(4):203-16. PubMed ID: 25720354
[TBL] [Abstract][Full Text] [Related]
10. Expression of MHC II genes.
Drozina G; Kohoutek J; Jabrane-Ferrat N; Peterlin BM
Curr Top Microbiol Immunol; 2005; 290():147-70. PubMed ID: 16480042
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-specific MHCII expression is regulated by a remote
Buxadé M; Huerga Encabo H; Riera-Borrull M; Quintana-Gallardo L; López-Cotarelo P; Tellechea M; Martínez-Martínez S; Redondo JM; Martín-Caballero J; Flores JM; Bosch E; Rodríguez-Fernández JL; Aramburu J; López-Rodríguez C
J Exp Med; 2018 Nov; 215(11):2901-2918. PubMed ID: 30327417
[TBL] [Abstract][Full Text] [Related]
12. Understanding the drivers of MHC restriction of T cell receptors.
La Gruta NL; Gras S; Daley SR; Thomas PG; Rossjohn J
Nat Rev Immunol; 2018 Jul; 18(7):467-478. PubMed ID: 29636542
[TBL] [Abstract][Full Text] [Related]
13. CIITA is not associated with risk of developing rheumatoid arthritis.
Bronson PG; Ramsay PP; Seldin MF; Gregersen PK; Criswell LA; Barcellos LF
Genes Immun; 2011 Apr; 12(3):235-8. PubMed ID: 21248776
[TBL] [Abstract][Full Text] [Related]
14. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA.
Muhlethaler-Mottet A; Otten LA; Steimle V; Mach B
EMBO J; 1997 May; 16(10):2851-60. PubMed ID: 9184229
[TBL] [Abstract][Full Text] [Related]
15. Structural aspects of the MHC expression control system.
Nash G; Paidimuddala B; Zhang L
Biophys Chem; 2022 May; 284():106781. PubMed ID: 35228036
[TBL] [Abstract][Full Text] [Related]
16. Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?
Kambayashi T; Laufer TM
Nat Rev Immunol; 2014 Nov; 14(11):719-30. PubMed ID: 25324123
[TBL] [Abstract][Full Text] [Related]
17. Triggering Degradation of Host Cellular Proteins for Robust Propagation of Influenza Viruses.
Xia C; Wang T; Hahm B
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731896
[TBL] [Abstract][Full Text] [Related]
18. Correlation analysis between HLA-DQA1*0102/DQB1*0602 genotypes and narcolepsy patients in China.
Zhao W; Zhang B; Yan Z; Zhao M; Zhang X; Zhang X; Liu X; Tang J
Front Neurol; 2024; 15():1379723. PubMed ID: 38725645
[TBL] [Abstract][Full Text] [Related]
19. Emerging strategies for treating autoimmune disease with genetically modified dendritic cells.
Ma Y; Shi R; Li F; Chang H
Cell Commun Signal; 2024 May; 22(1):262. PubMed ID: 38715122
[TBL] [Abstract][Full Text] [Related]
20. An HLA-E-targeted TCR bispecific molecule redirects T cell immunity against Mycobacterium tuberculosis.
Paterson RL; La Manna MP; Arena De Souza V; Walker A; Gibbs-Howe D; Kulkarni R; Fergusson JR; Mulakkal NC; Monteiro M; Bunjobpol W; Dembek M; Martin-Urdiroz M; Grant T; Barber C; Garay-Baquero DJ; Tezera LB; Lowne D; Britton-Rivet C; Pengelly R; Chepisiuk N; Singh PK; Woon AP; Powlesland AS; McCully ML; Caccamo N; Salio M; Badami GD; Dorrell L; Knox A; Robinson R; Elkington P; Dieli F; Lepore M; Leonard S; Godinho LF
Proc Natl Acad Sci U S A; 2024 May; 121(19):e2318003121. PubMed ID: 38691588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]